Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.22, $0.02 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $125.34 million versus the consensus estimate of $139.09 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.